---
title: "Coya Therapeutics presents ALSTARS Phase 2 trial design at ENCALS 2026 meeting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290194198.md"
description: "Coya Therapeutics will present the Phase 2 ALSTARS trial design for Coya 302 at the ENCALS Meeting 2026 in Madrid. The meeting takes place from June 24-26, 2026, with the poster presentation scheduled for June 24."
datetime: "2026-06-18T12:01:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290194198.md)
  - [en](https://longbridge.com/en/news/290194198.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290194198.md)
generator: "portal-rs"
---

# Coya Therapeutics presents ALSTARS Phase 2 trial design at ENCALS 2026 meeting

-   Coya Therapeutics will present the Phase 2 ALSTARS trial design for Coya 302 at the ENCALS Meeting 2026 in Madrid. \* The meeting runs June 24-26, 2026; the poster is scheduled for June 24, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260618774012) on June 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [COYA.US](https://longbridge.com/en/quote/COYA.US.md)

## Related News & Research

- [AgroGalaxy delays 2025 results release to Nov. 30, 2026](https://longbridge.com/en/news/297440664.md)
- [Systemair corrects dividend record date to Aug. 31, 2026 from Sept. 31 error](https://longbridge.com/en/news/297344953.md)
- [SoftwareOne attaches full H1 2026 report in correction to earlier release](https://longbridge.com/en/news/297010247.md)
- [Ameriprise Financial declares Q3 2026 dividend of R$ 1.48 per unit](https://longbridge.com/en/news/297021432.md)
- [Cemat publishes H1 2026 interim report](https://longbridge.com/en/news/297006906.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**